These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15005963)

  • 21. Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.
    Mohkam M; Karimi A; Gharib A; Daneshmand H; Khatami A; Ghojevand N; Sharifian M
    Pediatr Nephrol; 2007 May; 22(5):690-4. PubMed ID: 17226043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sonographic demonstration of pseudo-cholelithiasis after ceftriaxone].
    Barzilai M
    Harefuah; 1994 Sep; 127(5-6):163-5, 215. PubMed ID: 7995584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversible ceftriaxone-associated biliary pseudolithiasis in children.
    Schaad UB; Wedgwood-Krucko J; Tschaeppeler H
    Lancet; 1988 Dec; 2(8625):1411-3. PubMed ID: 2904533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children.
    Schaad UB; Suter S; Gianella-Borradori A; Pfenninger J; Auckenthaler R; Bernath O; Cheseaux JJ; Wedgwood J
    N Engl J Med; 1990 Jan; 322(3):141-7. PubMed ID: 2403654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudolithiasis due to ceftriaxone treatment for meningitis in children: report of 8 cases.
    Araz N; Okan V; Demirci M; Araz M
    Tohoku J Exp Med; 2007 Mar; 211(3):285-90. PubMed ID: 17347554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biliary pseudolithiasis in childhood: a case report.
    Herek O; Sarioğlu A; Koçer N; Tiryaki A; Akkemik B
    Eur J Pediatr Surg; 1999 Oct; 9(5):337-9. PubMed ID: 10584197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceftriaxone-induced biliary pseudolithiasis and urinary bladder sludge.
    Acun C; Erdem LO; Sogut A; Erdem CZ; Tomac N; Gundogdu S
    Pediatr Int; 2004 Jun; 46(3):368-70. PubMed ID: 15151561
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk factors leading to ceftriaxone-associated biliary pseudolithiasis in children.
    Kong MS; Chen CY
    Changgeng Yi Xue Za Zhi; 1996 Mar; 19(1):50-4. PubMed ID: 8935375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceftriaxone-associated Pseudolithiasis in the Gallbladder and Bile Duct of an Elderly Patient.
    Yamabe A; Irisawa A; Wakabayashi H; Tsunoda T; Tominaga K
    Intern Med; 2020 Nov; 59(21):2725-2728. PubMed ID: 32669492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gallstones in association with the use of ceftriaxone in children].
    Rodríguez Rangel DA; Pinilla Orejarena AP; Bustacara Diaz M; Henao García L; López Cadena A; Montoya Camargo R; Moreno LA
    An Pediatr (Barc); 2014 Feb; 80(2):77-80. PubMed ID: 23759541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children.
    Avci Z; Koktener A; Uras N; Catal F; Karadag A; Tekin O; Degirmencioglu H; Baskin E
    Arch Dis Child; 2004 Nov; 89(11):1069-72. PubMed ID: 15499067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A symptomatic child with ceftriaxone-associated biliary pseudolithiasis.
    Kutuya N; Ozaki Y; Okazaki T
    J Med Ultrason (2001); 2008 Sep; 35(3):125-8. PubMed ID: 27278835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis.
    de Moor RA; Egberts AC; Schröder CH
    Eur J Pediatr; 1999 Dec; 158(12):975-7. PubMed ID: 10592073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceftriaxone-induced pseudolithiasis in children treated for perforated appendicitis.
    Alemayehu H; Desai AA; Thomas P; Sharp SW; St Peter SD
    Pediatr Surg Int; 2014 Mar; 30(3):323-6. PubMed ID: 24464035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftriaxone-induced pseudolithiasis: not just a theoretical risk.
    Fan L; Lau P; Kapur J; Karthik SV
    Singapore Med J; 2017 Nov; 58(11):676-677. PubMed ID: 29167906
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ceftriaxone-associated pseudolithiasis in children].
    Zhang L; Yao Y
    Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):877-8. PubMed ID: 19099914
    [No Abstract]   [Full Text] [Related]  

  • 37. Pseudolithiasis after recent use of ceftriaxone: an unexpected diagnosis in a child with abdominal pain.
    von Martels JZ; Van de Meeberg EK; Holman M; Ligtenberg JJ; Ter Maaten JC
    Am J Emerg Med; 2013 Aug; 31(8):1294.e5-6. PubMed ID: 23809091
    [No Abstract]   [Full Text] [Related]  

  • 38. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.
    Prince JS; Senac MO
    Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study of nephrolithiasis occurrence in children receiving cefotriaxone.
    Youssef DM; Sherief LM; Sherbiny HS; ElAttar MY; Sheikh AR; Fawzy FM; Adham T
    Nephrology (Carlton); 2016 May; 21(5):432-7. PubMed ID: 26369807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy.
    Blais C; Duperval R
    Pediatr Radiol; 1994; 24(3):218-9. PubMed ID: 7936805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.